Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4545 - 4552 of 11613 results
Trends in Securities Class Actions Involving Life Sciences Companies
August 23, 2019| Video| Viewpoint
USCIS to Close Majority of its International Offices
August 22, 2019| Blog| Viewpoint
DOJ Seeks Dismissal of FCA Qui Tam Case to Escape Onerous Discovery Obligations
August 22, 2019| Blog| Viewpoint
Artificial Intelligence in the Employment Relationship: Friend or Foe?
August 21, 2019| Blog| Viewpoint
Infrastructure & Surface Transportation Update | ML Strategies
August 21, 2019| Alert| Viewpoint
Federal Circuit Cautions Against Rigid Approach to Prosecution History Estoppel in Fourth Appeal from ALIMTA® Litigations
August 19, 2019| Blog| Viewpoint
Proposed H-1B Cap Registration Fee Rule Cleared by OMB
August 16, 2019| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.